Radioiodine therapy with individualized dose protocol in a feline patient with hyperthyroidism
Case report
DOI:
https://doi.org/10.31533/pubvet.v18n01e1534Keywords:
Scintigraphy, iodine131, feline infectious anemia, thyroidAbstract
Hyperthyroidism is the most prevalent endocrinopathy in felines, especially in elderly cats. It consists of a multisystemic condition resulting from increased production of T3 and T4 by the thyroid gland. The etiology of the disease is due, in most cases, to adenomatous hyperplasia or glandular adenoma that leads to increased hormone production. The pathogenesis and risk factors of the disease are not yet well defined. Factors such as the consumption of endocrine disruptors have already been associated with the disease. The most common clinical manifestations are polyphagia associated with weight loss, vomiting and diarrhea, polyuria, polydipsia, hyperactivity and palpable nodules in the thyroid’s topography. Diagnosis is made based on anamnesis, clinical signs, results of laboratory and imaging tests, and measurement of thyroid and pituitary hormones. There are several therapeutic protocols such as the use of oral drugs, surgery, iodine-restricted diets and radioiodine therapy. This report aimed to describe the case of a feline, female, mixed breed, 11 years old, with a history of slight weight loss and sporadic episodes of emesis. Based on history and anamnesis, physical evaluation and findings from laboratory and imaging tests, including thyroid scintigraphy, the diagnosis of hyperthyroidism was made. The treatment carried out was the application of radioactive iodine with an individual dose based on the protocol proposed by Peterson and Rishniw (2021). Three months after the procedure, the values found for the hormonal tests (total T4 and TSH) were within the reference range and, currently, the patient is in a state of euthyroidism.
References
Boag, A. K., Neiger, R., Slater, L., Stevens, K. B., Haller, M., & Church, D. B. (2007). Changes in the glomerular filtration rate of 27 cats with hyperthyroidism after treatment with radioactive iodine. Veterinary Record, 161(21), 711–715. https://doi.org/10.1136/vr.161.21.711. PMID: 18037692.
Cardoso, M. J. L., Costa, F. S., Muniz, L. M. R., Zalith, A. C. A., Pandovani, C. R., & Aragon, F. F. (2005). Manifestações clínicas em gatos com hipertireoidismo experimental. Archives of Veterinary Science, 10(2), 135–144.
CNEN NN 6.12. (2022). Ministério da Ciência, tecnologia e inovações. Comissão nacional de energia nuclear. (2022). Requisitos de segurança e proteção radiológica para serviços radioterapia e medicina nuclear veterinária.
Daniel, G. B., Sharp, D. S., Nieckarz, J. A., & Adams, W. (2002). Quantitative thyroid scintigraphy as a predictor of serum thyroxin concentration in normal and hyperthyroid cats. Veterinary Radiology & Ultrasound, 43(4), 374–382. https://doi.org/10.1111/j.1740-8261.2002.tb01021.x.
Feldman, E. C., Nelson, R. W., Reusch, C., & Scott-Moncrieff, J. C. (2014). Canine and feline endocrinology-e-book. Elsevier health sciences.
Gregory, B. D., & Neelis, D. A. (2014). Thyroid scintigraphy in veterinary medicine. Seminars in Nuclear Medicine, 44(1), 24–34.
Lucy, J. M., Peterson, M. E., Randolph, J. F., Scrivani, P. V, Rishniw, M., Davignon, D. L., Thompson, M. S., & Scarlett, J. M. (2017). Efficacy of low‐dose (2 millicurie) versus standard‐dose (4 millicurie) radioiodine treatment for cats with mild‐to‐moderate hyperthyroidism. Journal of Veterinary Internal Medicine, 31(2), 326–334. https://doi.org/10.1111/jvim.14646.
Lurye, J. C. (2006). Update on treatment of hyperthyroidism. Consultations in Feline Internal Medicine, 23, 199–205.
McAfee, J. G., & Subramanian, G. (1984). Radioactive agents for imaging. In Freeman and Johnson’s clinical radionuclide imaging (pp. 55–179). Grune & Atratton Inc.
Meric, S. M., & Rubin, S. I. (1990). Serum thyroxine concentrations following fixed-dose radioactive iodine treatment in hyperthyroid cats: 62 cases (1986-1989). Journal of the American Veterinary Medical Association, 197(5), 621–623.
Milner, R. J., Channell, C. D., Levy, J. K., & Schaer, M. (2006). Survival times for cats with hyperthyroidism treated with iodine 131, methimazole, or both: 167 cases (1996–2003). Journal of the American Veterinary Medical Association, 228(4), 559–563. https://doi.org/10.2460/javma.228.4.559.
Nykamp, S. G., Dykes, N. L., Zarfoss, M. K., & Scarlett, J. M. (2005). Association of the risk of development of hypothyroidism after iodine 131 treatment with the pretreatment pattern of sodium pertechnetate Tc 99m uptake in the thyroid gland in cats with hyperthyroidism: 165 cases (1990–2002). Journal of the American Veterinary Medical Association, 226(10), 1671–1675. https://doi.org/10.2460/javma.2005.226.1671.
Peterson, M. E. (1984). Hyperadrenocorticism. The Veterinary Clinics of North America. Small Animal Practice, 14(4), 731–749.
Peterson, M. E. (2013). More than just T4: diagnostic testing for hyperthyroidism in cats. Journal of Feline Medicine and Surgery, 15(9), 765–777. https://doi.org/10.1177/1098612X13500426.PMID: 23966003.
Peterson, M. E., & Becker, D. V. (1984). Radionuclide thyroid imaging in 135 cats with hyperthyroidism. Veterinary Radiology, 25(1), 23–27. https://doi.org/10.1111/j.1740-8261.1984.tb00737.x.
Peterson, M. E., Guterl, J. N., Rishniw, M., & Broome, M. R. (2016). Evaluation of quantitative thyroid scintigraphy for diagnosis and staging of disease severity in cats with hyperthyroidism: Comparison of the percent thyroidal uptake of pertechnetate to thyroid‐to‐salivary ratio and thyroid‐to‐background ratios. Veterinary Radiology & Ultrasound, 57(4), 427–440. https://doi.org/10.1111/vru.12360. Epub 2016 Apr 6.
Peterson, M. E., Kintzer, P. P., Cavanagh, P. G., Fox, P. R., Ferguson, D. C., Johnson, G. F., & Becker, D. V. (1983). Feline hyperthyroidism: pretreatment clinical and laboratory evaluation of 131 cases. Journal of the American Veterinary Medical Association, 183(1), 103–110.
Peterson, M. E., & Rishniw, M. (2021). A dosing algorithm for individualized radioiodine treatment of cats with hyperthyroidism. Journal of Veterinary Internal Medicine, 35(5), 2140–2151. https://doi.org/10.1111/jvim.16228.
Peterson, M. E., & Turrel, J. M. (1982). Feline hyperthyroidism. Veterinary Clinics of North America: Small Animal Practice, 14(4), 809–826.
Peterson, M. E., & Ward, C. R. (2007). Etiopathologic findings of hyperthyroidism in cats. Veterinary Clinics of North America: Small Animal Practice, 37(4), 633–645. https://doi.org/10.1016/j.cvsm.2007.05.001.
Trepanier, L. A. (2006). Medical management of hyperthyroidism. Clinical Techniques in Small Animal Practice, 21(1), 22–28. https://doi.org/10.1053/j.ctsap.2005.12.004.
Xifra, P., Serrano, S. I., & Peterson, M. E. (2022). Radioiodine treatment of hyperthyroidism in cats: results of 165 cats treated by an individualised dosing algorithm in Spain. Journal of Feline Medicine and Surgery, 24(8), e258–e268. https://doi.org/10.1177/1098612X221104743.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Fernanda Batista de Oliveira Santos, Gustavo Carvalho Cobucci, Juliana Silva Costa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato
Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
O licenciante não pode revogar estes direitos desde que você respeite os termos da licença. De acordo com os termos seguintes:
Atribuição
— Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso. Sem restrições adicionais
— Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
